- 现金
- 222032 元
- 精华
- 285
- 帖子
- 67620
- 注册时间
- 2001-11-10
- 最后登录
- 2023-5-7
|
1楼
发表于 2003-7-30 03:51
[B]with biochemical markers in patients with chronic hepatitis B.[/B]
J Hepatol. 2003 Aug;39(2):222-30. Links
Myers RP, Tainturier MH, Ratziu V, Piton A, Thibault V, Imbert-Bismut F,
Messous D, Charlotte F, Di Martino V, Benhamou Y, Poynard T.
Department of Hepatology and Gastroenterology, Groupe Hospitalier
Pitie-Salpetriere, Paris, France
BACKGROUND AIMS: Liver biopsy is the gold standard for assessing hepatitis B
virus (HBV)-related histology. The aim was to determine the diagnostic
utility of noninvasive serum markers in patients with chronic hepatitis
B.METHODS: The aminotransferases and indices including
alpha(2)-macroglobulin, apolipoprotein A1, haptoglobin,
gamma-glutamyl-transpeptidase (GGT), and total bilirubin (Fibrotest), and
ALT (Actitest) were compared with liver histology. The primary outcomes were
A2-A3 activity and F2-F4 fibrosis (METAVIR).RESULTS: Two hundred and nine
patients were included. Forty-one patients (20%) had A2-A3 activity and 61
(29%) had F2-F4 fibrosis. AST and GGT (P<0.001) were independently
associated with A2-A3 activity. AST, ALT, and Actitest accurately predicted
activity ((areas under receiver operating characteristic (ROC) curves
(AUROC), 0.81-0.82+/-0.04)); an AST or ALT0.80 had
negative and positive predictive values of 92%, respectively. Restricting
biopsy to patients with intermediate scores (>0.20 and |
|